Pacritinib RC10993
2 Inquiries
937272-79-2
Pharmaceutical Grade
99%
Royalchem
25kg/drum
Yes
2030-01-01
Pharmaceutical intermediates
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferencePacritinib is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM). Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM).
Pacritinib is under investigation for the prevention of Acute Myeloid Leukemia (AML).|Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Oral JAK2 inhibitor SB1518 competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity.Basic Info-
Product Name:
Pacritinib
Other Name:14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene,11-[2-(1-pyrrolidinyl)ethoxy]-,(16E)-;(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene;Pacritinib;SB 1518;1138325-13-9
CAS No.:937272-79-2
Molecular Formula:C28H32N4O3
InChIKeys:InChIKey=HWXVIOGONBBTBY-ONEGZZNKSA-N
Molecular Weight:472.59
Exact Mass:472.58
UNII:G22N65IL3O
NCI Thesaurus Code:C78837
Categories:
Characteristics-
PSA:
68.7
XLogP3:3.8
Density:1.2±0.1 g/cm3
Boiling Point:694.3±65.0°C at 760 mmHg
Flash Point:384.0±35.7 °C
Refractive Index:1.574
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceutical intermediates
-
Location:
Room 336, Building 7, No. 177 Xingqiao North Road, Xingqiao Street, Linping District, Hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
14 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
India
pacritinib
1 G Jan 3, 2024
India
Pacritinib
5 G Jan 3, 2024 Post an enquiry for this product
More from this Seller
-
-
-
1-Bromo-7-chloroheptane RC03058
Industrial Grade / 99%
$1/KG EXW
-
-
-
-
4-Benzofurancarboxylic acid RC00120
Pharmaceutical Grade / 97.0%
-
-
-
-
1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole RC11576
Industrial Grade / 99%
$1/KG EXW
-
-
-
-
Bear Bile 98.5%Min White powder RC01071
Food Grade / 98.5%
-
-
-
-
(Bromomethyl)boronic Acid Pinacol Ester RC04587
Industrial Grade / 99%
$1/KG EXW
-
-
-
-
Chelidonic acid RC05140
Industrial Grade / 99%
$1/KG EXW
-